Toward Precision Medicine in Pulmonary Arterial Hypertension. Austin ED, Loyd JE (2015) Am J Respir Crit Care Med 192: 1272-4 Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity. Hunley TE, Fogo A, Iwasaki S, Kon V (1995) J Am Soc Nephrol 5: 1718-23 Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Fogo A, Hellings SE, Inagami T, Kon V (1992) Kidney Int 42: 770-4 Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Saleh MA, Boesen EI, Pollock JS, Savin VJ, Pollock DM (2010) Hypertension 56: 942-9 Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Saleh MA, Boesen EI, Pollock JS, Savin VJ, Pollock DM (2011) Diabetologia 54: 979-88 Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study. Hay BR, Pugh ME, Robbins IM, Hemnes AR (2016) Chest 149: 660-6 Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease. Saleh MA, Pollock JS, Pollock DM (2011) J Pharmacol Exp Ther 338: 263-70 Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats. Kon V, Hunley TE, Fogo A (1995) Transplantation 60: 89-95 Combination therapy in pulmonary arterial hypertension. Pugh ME, Hemnes AR, Robbins IM (2013) Clin Chest Med 34: 841-55 Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Robbins IM, Hemnes AR, Gibbs JS, Christman BW, Howard L, Meehan S, Cabrita I, Gonzalez R, Oyler T, Zhao L, Du RH, Mendes LA, Wilkins MR (2011) Exp Lung Res 37: 26-34
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.